Complete Filing Data
GENOIL INC reported Stockholders Equity of -$10.79 million for FY2022.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean GENOIL INC did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2022 | FY2021 | FY2020 |
|---|---|---|---|
| Revenues | $0.00 | $0.00 | $0.00 |
| Operating Income Loss | -$1.6M | -$1.1M | -$3.8M |
| Operating Expenses | $1.6M | $1.1M | $3.8M |
| Net Income Loss | -$3.6M | -$2.4M | -$4.5M |
| Interest Expense Added To Convertible Notes | $394.8K | $221.4K | $0.00 |
| Income Taxes Paid Net | $0.00 | $0.00 | $0.00 |
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$3.6M | -$2.4M | -$4.5M |
| Gross Profit | $0.00 | $0.00 | $0.00 |
| Nonoperating Income Expense | -$1.9M | -$1.4M | -$718.7K |
| Net Income Loss Attributable To Common Shareholders | -$3.6M | -$2.5M | -$4.5M |
| Interest Expense | $1.9M | $1.4M | $718.7K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|
| Stockholders Equity | -$10.8M | -$8.9M | -$7.6M | -$7.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $5.0K | $12.00 | $3.4K | $1.4K |
| Retained Earnings Accumulated Deficit | -$99.3M | -$95.8M | -$93.3M | |
| Prepaid Expense And Other Assets Current | $4.4K | $8.6K | $0.00 | |
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | |
| Liabilities Noncurrent | $0.00 | $0.00 | $4.7M | |
| Liabilities Current | $11.1M | $9.2M | $3.1M | |
| Liabilities And Stockholders Equity | $325.8K | $272.1K | $199.3K | |
| Liabilities | $11.1M | $9.2M | $7.8M | |
| Convertible Debt Noncurrent | $0.00 | $0.00 | $4.7M | |
| Common Stock Value | $51.5M | $50.9M | $50.5M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $5.0K | -$3.4K | $2.0K | |
| Assets Current | $282.7K | $228.9K | $156.1K | |
| Assets | $325.8K | $272.1K | $199.3K | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$221.9K | -$221.9K | -$221.9K | |
| Accounts Payable And Accrued Liabilities Current | $115.3K | $111.3K | $70.1K | |
| Convertible Notes Payable Current | $5.3M | $4.9M | $0.00 | |
| proceeds Net Change In Related Party Payables | $0.00 | -$17.8K | -$64.7K | |
| Repayments Net Change In Related Party Receivables | $52.9K | $67.6K | $154.1K | |
| Preferred Stock Dividends And Other Adjustments | -$780.00 | -$85.9K | $0.00 | |
| Intangible Assets Net Excluding Goodwill | $1.00 | $1.00 | $1.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2022 | FY2021 | FY2020 |
|---|---|---|---|
| Share Based Compensation | $1.2M | $717.2K | $3.5M |
| Proceeds From Sale Of Equity Method Investments | $456.4K | $399.3K | $421.5K |
| Net Cash Provided By Used In Operating Activities | -$398.5K | -$317.2K | -$330.1K |
| Net Cash Provided By Used In Financing Activities | $403.5K | $313.8K | $332.1K |
| Stock Issued During Period Value Share Based Compensation | $1.1M | $659.8K | $3.3M |
| Increase Decrease In Trade And Other Payables | $4.0K | $41.2K | $9.9K |
| Increase Decrease In Prepaid Expense | -$4.2K | $8.6K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2022 | FY2021 | FY2020 |
|---|---|---|---|
| Weighted Average Shares Outstanding Basic And Diluted | 669.8M | 618.1M | 583.0M |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 640.6M | 596.2M | 0.00 |
| Common Stock Shares Issued | 696.0M | 596.2M | 0.00 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
| Net Loss Per Share Basic And Diluted | $-0.01 | $0.00 | $-0.01 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2022 | FY2021 | FY2020 |
|---|---|---|---|
| Stock Issued During Period Value Issued For Services | $97.4K | $57.4K | $191.3K |
| Sale Of Common Shares And Warrants In Private Placements Amount | 456.4K | 399.3K | 421.5K |
| Land | $43.2K | $43.2K | $43.2K |
| Interest Paid Net | $0.00 | $0.00 | $0.00 |
| Deemed Dividends Related To Issuance Of Warrants | $780.00 | $85.9K | $0.00 |
| Deemed Dividends | $0.00 | $0.00 | |
| Satisfaction Of Amounts Due | $0.00 | $0.00 | $3.9M |
| Salaries Wages And Officers Compensation | $1.2M | $717.2K | $3.5M |
| Reduction Of Amounts Due From David Lifschultz And Bruce Abbott | $0.00 | $0.00 | $1.7M |
| Other Cost And Expense Operating | $406.7K | $349.8K | $340.0K |
| Issuance Of New Convertible Debentures To David Lifschultz And Bruce Abbott | $0.00 | $0.00 | $2.2M |
Most recent annual filing with the SEC: May 2, 2023
Data sourced from SEC EDGAR public filings as of August 6, 2026.